ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BFRI vs DARE // GROSS PROFIT MARGIN

Biofrontera Inc. (NASDAQ) VS. Dare Bioscience Inc. (NASDAQ) • 15-METRIC TALLY: BFRI 4 — DARE 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BFRI VS. DARE) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BFRI DARE SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 71.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -27.20% -60.00% +32.80 BFRI /operating-margins <GO>
Net Profit Margin -25.30% -60.00% +34.70 BFRI /net-margins <GO>
Revenue Growth (YoY) 11.70% 180.00% -168.30 DARE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 4/9 -1.00 DARE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.7 39.6 +9.10 BFRI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $13.8M $13.4M $430.5K BFRI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BFRI REV DARE REV BFRI GROSS % DARE GROSS % BFRI FCF DARE FCF
FY 2025 $41.7M $1.0M — 71.3% -$13.4M -$10.3M
FY 2024 $37.3M $9.8K — 98.0% -$10.3M $4.9M
FY 2023 $34.1M $2.8M — — -$24.9M -$38.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BFRI // BETA —
DARE // BETA —